Tuesday, 25 February 2020

Vyaire Medical appoints Gaurav Agarwal as CEO

22 January 2020 | News

Vyaire Medical is the largest company in the global healthcare ecosystem fully dedicated to respiratory care

image credit- shuttershock.com

image credit- shuttershock.com

Vyaire Medical has announced that its Board of Directors has appointed Gaurav Agarwal as Chief Executive Officer, effective immediately. Agarwal succeeds Dave Eckley, who is stepping down as Chief Executive Officer, but will remain on the company's Board of Directors.

Vyaire Medical is the largest company in the global healthcare ecosystem fully dedicated to respiratory care. With a vision of enabling, improving and extending the lives of patients, the company is committed to innovating and delivering the best respiratory solutions to healthcare customers around the world. 

Agarwal brings to Vyaire Medical extensive global leadership experience in medical devices and a proven track record in driving innovation, improving patient outcomes, and creating exceptional value for customers. Most recently, as President and Chief Operating Officer of KCI, an Acelity company, Agarwal transformed the company into an undisputed leader in advanced wound care, by finding ground-breaking healing solutions for current and new customer segments. Prior to that, he served as President, Orthopaedic Reconstruction at Smith & Nephew, where he was responsible for defining a cutting-edge global strategy that expedited product development and redefined the company's portfolio for joint reconstruction. Before that, he held Vice President and General Manager positions at GE Healthcare.

In 2019, the company launched several new products. Most notably, the bellavista 1000e was introduced in the US, a uniquely versatile ventilator system that allows one device to work across a broad range of patients and situations – enhancing workflow, simplifying training, and improving patient outcomes. Two of the latest Pulmonary Function Testing (PFT) technologies were also introduced in the US: VyntusTM BODY and VyntusTM ONE, both with SentrySuiteTM software. Internationally, SuperNO2VA, the exclusive nasal ventilation mask was brought to market.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account